FMC Corporation filings document the regulatory record of a NYSE-listed agricultural sciences company with common stock trading under FMC. Recent 8-K reports disclose operating results, material credit-agreement amendments, financial covenants, subsidiary guarantees, collateral arrangements, dividend limitations, restructuring charges, and governance changes.
Proxy materials describe annual meeting matters, stockholder voting procedures, and equity incentive plan approvals. Together, the filings cover FMC's capital structure, board oversight, compensation programs, manufacturing footprint actions, risk-related covenant terms, and recurring financial reporting for its crop protection business.
A director of FMC Corporation acquired additional common shares through an equity compensation feature rather than an open-market trade. On January 15, 2026, Eduardo E. Cordeiro was issued 88 shares of FMC common stock at a price of $0 per share. These shares were granted pursuant to dividend equivalent rights tied to previously vested restricted stock units held by him.
After this issuance, Cordeiro directly holds 31,634 shares of FMC common stock. The transaction reflects routine alignment of his holdings with dividend payments associated with vested equity awards.
FMC Corporation director Carol Anthony Davidson received 49 shares of FMC common stock on January 15, 2026. The shares were issued at $0 under dividend equivalent rights tied to restricted stock units that had already vested. Following this small equity award, Davidson beneficially owns 23,276 FMC common shares directly.
FMC Corporation director Kathy Lynn Fortmann reported receiving 63 shares of common stock on January 15, 2026. The shares were issued at a price of $0 per share pursuant to dividend equivalent rights tied to vested restricted stock units held by the director. Following this issuance, she beneficially owned 14,326 shares of FMC common stock directly.
FMC Corporation director C. Scott Greer reported a small equity award. On January 15, 2026, he acquired 167 shares of FMC common stock at a price of $0 per share, bringing his directly held beneficial ownership to 74,465 shares. According to the disclosure, these 167 shares were issued under dividend equivalent rights that accrued on previously granted restricted stock units once those units vested. This reflects an automatic, compensation-related share issuance rather than an open-market purchase or sale.
FMC Corporation director K'Lynne Johnson reported a small increase in her direct share ownership through a Form 4 filing. On 01/15/2026, she acquired 146 shares of FMC common stock at a price of $0 per share. The filing explains that these shares were issued as dividend equivalent rights connected to previously vested restricted stock units held by Johnson, meaning she received additional shares in lieu of cash dividends on those units. Following this transaction, she beneficially owns 35,069 FMC common shares directly. This was a routine equity-based compensation-related issuance rather than an open-market purchase or sale.
FMC Corporation director Dirk A. Kempthorne reported receiving 250 shares of FMC common stock on January 15, 2026. The shares were issued at $0 per share as dividend equivalent rights tied to vested restricted stock units held by the reporting person. After this transaction, Kempthorne directly beneficially owns 56,710 shares of FMC common stock.
FMC Corporation director Steven T. Merkt reported a small increase in his ownership of FMC common stock. On 01/15/2026, he acquired 15 shares of common stock at a price of $0 per share, bringing his directly held stake to 5,866 shares.
The filing explains that these shares were issued under dividend equivalent rights tied to vested restricted stock units already held by Merkt. This means he received additional shares to mirror dividends that would have been paid on those underlying restricted stock units, rather than through an open‑market purchase or sale.
FMC Corporation director Margareth Oevrum reported the acquisition of 103 shares of common stock on January 15, 2026. The shares were issued at $0 per share pursuant to dividend equivalent rights connected to vested restricted stock units held by her. Following this issuance, she directly owns 22,409 FMC common shares.
FMC Corporation director Robert C. Pallash received additional equity compensation in the form of common stock. On January 15, 2026, he acquired 306 shares of FMC common stock at a price of $0.00 per share through dividend equivalent rights connected to vested restricted stock units held by him. After this transaction, he directly beneficially owned 60,422 FMC common shares. This was a Form 4 filing by a single reporting person in his capacity as a director, reflecting a routine equity-based compensation accrual rather than an open‑market trade.
FMC director John Mitchell Raines reported a small equity award in the form of company stock. On January 15, 2026, he acquired 20 shares of FMC common stock at a price of $0 per share, bringing his total directly held FMC shares to 13,804 after the transaction. The shares were issued pursuant to dividend equivalent rights tied to previously vested restricted stock units, meaning he received additional shares in lieu of cash dividends on those vested awards.